Comparison between whole‐body magnetic resonance imaging and whole‐body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma

Author:

Rodrigues Monica Matos Correia1,Lederman Henrique Manoel2,Grossman Iona2,Castiglioni Mario Luiz V.3,Marchetti Renata3,Grass Daphne Centola2,Luisi Flavio Augusto Vercillo1ORCID,Caran Eliana Maria Monteiro1

Affiliation:

1. Division of Pediatric Oncology Institute of Pediatric Oncology, Support Group for Adolescents and Children with Cancer/Paulista School of Medicine, Federal University of São Paulo (Escola Paulista de Medicina, Universidade Federal de São Paulo) São Paulo São Paulo Brazil

2. Division of Radiology Institute of Pediatric Oncology, Support Group for Adolescents and Children with Cancer (IOP/GRAACC)/Paulista School of Medicine, Federal University of São Paulo (Escola Paulista de Medicina, Universidade Federal de São Paulo) São Paulo São Paulo Brazil

3. Nuclear Medicine ‐ Imaging Diagnostic Department (DDI), HU Federal University of São Paulo (UNIFESP) São Paulo São Paulo Brazil

Abstract

AbstractBackgroundWhole‐body metaiodobenzylguanidine (131I‐MIBG) scintigraphy is the gold standard method to detect neuroblastoma; however, it depends on radioactive material and is expensive. In contrast, whole‐body magnetic resonance imaging (WB‐MRI) is affordable in developing countries and has been shown to be effective in the evaluation of solid tumors. This study aimed to compare the sensitivity and specificity of WB‐MRI with MIBG in the detection of primary tumors and neuroblastoma metastases.ProcedureThis retrospective study enrolled patients with neuroblastoma between 2013 and 2020. All patients underwent WB‐MRI and MIBG at intervals of up to 15 days. The results were marked in a table that discriminated anatomical regions for each patient. Two experts evaluated, independently and in anonymity, the WB‐MRI images, and two others evaluated MIBG. The results were compared in terms of sensitivity and specificity, for each patient, considering MIBG as the gold standard. This study was approved by the UNIFESP Ethics Committee.ResultsThirty patients with neuroblastoma were enrolled in this study. The age ranged from 1 to 15 years, with a mean of 5.7 years. The interval between exams (WB‐MRI and MIBG) ranged from 1 to 13 days, with an average of 6.67 days. Compared to MIBG, WB‐MRI presented a sensitivity and specificity greater than or equal to 90% for the detection of primary neuroblastoma in bones and lymph nodes. When we consider the patient without individualizing the anatomical regions, WB‐MRI presented sensitivity of 90% and specificity of 73.33%.ConclusionIn conclusion, WB‐MRI is a sensitive and specific method to detect neuroblastoma in bone and lymph nodes and highly sensible to primary tumor diagnosis, suggesting that this test is a viable alternative in places where MIBG is difficult to access. Studies with a larger number of cases are necessary for definitive conclusions.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3